Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: OpiCapone Effect on Motor Fluctuations and pAiN [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating OpiCapone in Parkinson's disease to assess effects on motor fluctuations and pain; the study completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OpiCapone

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-03-28